• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压患者的尿激肽释放酶排泄及血浆多巴胺β-羟化酶活性

Urinary kallikrein excretion and plasma DBH activity in hypertension.

作者信息

Greco A V, Porcelli G, Magalhaes J F, Altomonte L

出版信息

Agents Actions. 1978 Dec;8(6):572-5. doi: 10.1007/BF01998885.

DOI:10.1007/BF01998885
PMID:742555
Abstract

Many factors are to be considered in maintaining normal blood pressure. Authors study the behavior of urinary kallikrein (U.K.) and plasma dopamine-beta-hydroxylase (DBH) activity in various forms of hypertension. The values of U.K. excretion in normals were 20.5 +/- 1.8 E.U./24 h. In essential hypertensive patients (9.4 +/- 2.0 E.U./24 h) U.K. decreased, while in secondary hypertension it was significantly higher (33.8 +/- 3.0 E.U./24 h). Plasma DBH activity in essential hypertensive patients (17.72 +/- 2.33 I.U./ml) was similar to controls (20.22 +/- 1.39 I.U./ml); in secondary hypertension the mean values of plasma DBH were decreased (12.31 +/- 2.55 I.U./ml). No correlation between U.K. and plasma DBH activity was observed in normals and in various forms of hypertensive patients. U.K. seems a more reliable factor than plasma DBH in defining the different types of hypertension.

摘要

维持正常血压需要考虑许多因素。作者研究了尿激肽释放酶(U.K.)的行为以及血浆多巴胺-β-羟化酶(DBH)活性在各种高血压类型中的情况。正常人尿激肽释放酶的排泄值为20.5±1.8国际单位/24小时。原发性高血压患者的尿激肽释放酶排泄值降低(9.4±2.0国际单位/24小时),而继发性高血压患者的排泄值显著升高(33.8±3.0国际单位/24小时)。原发性高血压患者的血浆DBH活性(17.72±2.33国际单位/毫升)与对照组(20.22±1.39国际单位/毫升)相似;继发性高血压患者血浆DBH的平均值降低(12.31±2.55国际单位/毫升)。在正常人和各种高血压患者中,未观察到尿激肽释放酶与血浆DBH活性之间存在相关性。在区分不同类型的高血压方面,尿激肽释放酶似乎比血浆DBH更可靠。

相似文献

1
Urinary kallikrein excretion and plasma DBH activity in hypertension.高血压患者的尿激肽释放酶排泄及血浆多巴胺β-羟化酶活性
Agents Actions. 1978 Dec;8(6):572-5. doi: 10.1007/BF01998885.
2
The evaluation of plasma dopamine beta-hydroxylase activity in essential and secondary hypertension.
Jpn Heart J. 1979 May;20(3):307-20. doi: 10.1536/ihj.20.307.
3
Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension.
Science. 1974 Feb 8;183(4124):523-5. doi: 10.1126/science.183.4124.523.
4
Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
Circulation. 1979 May;59(5):1063-9. doi: 10.1161/01.cir.59.5.1063.
5
The meaning of dopamine beta-hydroxylase in essential hypertension.多巴胺β-羟化酶在原发性高血压中的意义。
Clin Sci Mol Med. 1975 Dec;49(6):573-9. doi: 10.1042/cs0490573.
6
Urinary kallikrein excretion and sodium metabolism in hypertensive patients.高血压患者的尿激肽释放酶排泄与钠代谢
Tohoku J Exp Med. 1975 Aug;116(4):359-367. doi: 10.1620/tjem.116.359.
7
Dopamine-beta-hydroxylase. An index of adrenergic function in hypertensive patients.多巴胺-β-羟化酶。高血压患者肾上腺素能功能指标。
West J Med. 1975 Aug;123(2):108-114.
8
Cerebrospinal fluid and plasma dopamine-beta-hydroxylase activity in human hypertension.
Hypertension. 1981 Jul-Aug;3(4):448-55. doi: 10.1161/01.hyp.3.4.448.
9
Studies on the role of sympathetic nervous system in the mechanism of essential hypertension.
Jpn Circ J. 1977 Mar;41(3):228-36. doi: 10.1253/jcj.41.228.
10
Plasma dopamine-beta-hydroxylase activity and blood pressure variability in hypertensive man.高血压患者的血浆多巴胺-β-羟化酶活性与血压变异性
Clin Endocrinol (Oxf). 1979;11(2):187-99. doi: 10.1111/j.1365-2265.1979.tb03065.x.

本文引用的文献

1
Kallikrein-like activity in the urine of renal hypertensive rats.肾性高血压大鼠尿液中的激肽释放酶样活性。
Experientia. 1970 Nov 15;26(11):1216-7. doi: 10.1007/BF01897974.
2
Urinary kallikrein excretion in hypertension.
Circ Res. 1972 Sep;31(9):Suppl 2:125-31.
3
Photometric assay of dopamine- -hydroxylase activity in human blood.人血中多巴胺-β-羟化酶活性的光度测定
Clin Chem. 1972 Sep;18(9):980-3.
4
[Arterial hypertension and urinary kallikrein].
Minerva Med. 1974 Aug 18;65(58):3058-62.
5
Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.6-羟基多巴胺对肾上腺多巴胺-β-羟化酶的抑制作用。
Biochem Pharmacol. 1973 Oct 15;22(20):2581-9. doi: 10.1016/0006-2952(73)90066-x.
6
Plasma dopamine -hydroxylase and noradrenaline amounts in essential hypertension.
Clin Sci. 1973 Jun;44(6):617-20. doi: 10.1042/cs0440617.
7
Human serum dopamine- -hydroxylase. Relationship to hypertension and sympathetic activity.
Circ Res. 1973 May;32(5):594-9. doi: 10.1161/01.res.32.5.594.
8
Plasma norepinephrine levels in essential hypertension.原发性高血压患者的血浆去甲肾上腺素水平
N Engl J Med. 1973 Mar 22;288(12):599-601. doi: 10.1056/NEJM197303222881203.
9
Dopamine-beta-hydroxylase in hypertension.高血压中的多巴胺-β-羟化酶
Acta Med Scand. 1974 Jul-Aug;196(1-2):17-20. doi: 10.1111/j.0954-6820.1974.tb00960.x.
10
Plasma dopamine- -hydroxylase activity in hypertension and various neuropsychiatric disorders.高血压及各种神经精神疾病中的血浆多巴胺-β-羟化酶活性
Scand J Clin Lab Invest. 1972 Nov;30(3):283-9. doi: 10.3109/00365517209084292.